Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2005-07-05
2005-07-05
Graser, Jennifer E. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S184100, C435S243000, C435S252100
Reexamination Certificate
active
06913754
ABSTRACT:
The invention provides and immune stimulating agent or vaccine directed toRenibacterium salmoninarumcomprising a live non-virulent culture of anArthrobacterstrain based on, derived from or substantially homologous with strain RSxII as deposited as ATCC 55921. The culture may be presented in lyophilized form with a sterile diluent.
REFERENCES:
patent: WO 96/11717 (1996-04-01), None
Koch et al., “16S rDNA Studied on Membranes of Arthrobacter and Micrococcus: An Aid for their Future Taxonomic Restructuring”, FEMS Microbiology Letters, vol. 123, pp. 167-171, (1994).
S.G. Griffiths et al., “Reduction of Renibacterium Culture Activity in Atlantic Salmon Following Vaccination with Avirulent Strains”, Fish & Shelfish Immunology, vol. 8, pp. 607-619, (1998).
Mori et al. Bull. JPN Soc Sci Fish, 46(6): 717-722, (1980) Abstract only.
Karaskiewicz, J. Pr. Inst. Naft. Poland, V20505/IB, 1974, p. 67, Abstract only.
Griffiths Steven Gareth
Salonius Kira
Graser Jennifer E.
Marks David L.
Novartis AG
LandOfFree
Renibacterium salmoninarum vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Renibacterium salmoninarum vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Renibacterium salmoninarum vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3367398